As of 17 Sept 2026, Mankind Pharma Ltd share price is ₹2,255.30. The stock opened at ₹2,255.30 and had closed at ₹2,248.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,909.90 and a high of ₹2,670.00. In terms of performance, Mankind Pharma Ltd share price has increased by 6.93% over the past six months and has decreased by 14.79% over the last year.
MANKIND Stock Price Chart
Mankind Pharma Ltd Overview
About MANKIND
Mankind Pharma engaged in the manufacturing and trading of pharmaceuticals and health care products. The Company has three manufacturing facilities at Paonta Sahib in the state of Himachal Pradesh, one manufacturing facility in state of Sikkim, two manufacturing facilities in state of Rajasthan, one manufacturing facility in state of Andhra Pradesh, three in-house research and development centres in the state of Haryana and one research and development centre in the state of Maharashtra to carry out research in pharmaceutical products.
Mankind Pharma Ltd Historical Performance
MANKIND Futures & Options
Mankind Pharma Ltd Fundamentals
Mankind Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 10,747.28 | 10,000.83 | 8,899.75 | 8,289.93 | 7,690.03 |
| EBITDA | 3,305.78 | 2,918.24 | 2,536.79 | 1,860.17 | 2,041.89 |
| Net Profit | 2,037.56 | 1,785.99 | 1,876.16 | 1,248.26 | 1,389.42 |
| EPS | 49.37 | 44.22 | 45.52 | 31.16 | 34.68 |
Mankind Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 2,230.00 |
| Resistance 1 (R1) | 2,283.00 |
| Pivot Point | 2,265.00 |
Mankind Pharma Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 08-Aug-2025 | 31-Jul-2025 | 08-Aug-2025 | Interim | ₹1.00 |
MANKIND Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| RAMESH CHAND JUNEJA | Chairman & Managing Director |
| RAJEEV JUNEJA | Vice Chairman & M.D. |
| SHEETAL ARORA | Chief Executive Officer |
Mankind Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,853.50+0.00% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,158.00+0.00% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,810.00-0.05% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Mankind Pharma Ltd today is ₹2,255.30 on NSE and ₹2,255.30 on BSE.
- The 52-week high of Mankind Pharma Ltd is ₹2,670.00, while the 52-week low is ₹1,909.90.
- The current market capitalisation of Mankind Pharma Ltd is approximately ₹92,853 crore.
- The P/E (Price-to-Earnings) ratio of Mankind Pharma Ltd is 50.48. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Mankind Pharma Ltd is 5.95. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Mankind Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for MANKIND on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Mankind Pharma Ltd has delivered a return of approximately 27.39%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Mankind Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 72.63% promoters, -1.42% FIIs, 15.39% DIIs, and 1.29% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
